Endocrine disruption during pregnancy and genetic drivers of bone disease were among the topics experts from UC San Francisco presented at the annual meeting of the Endocrine Society — ENDO 2025 — in ...

Weber – who was briefly chief operating officer of Takeda before rising to the CEO role and was the first non-Japanese person to lead the 243-year-old company – will be replaced by Julie Kim ...

In this valuable study, the authors provide a simple yet elegant approach to identifying therapeutic targets that synergize to prevent therapeutic resistance in ovarian cancer using cell lines, ...